Thymidine-5'-triphosphate (Pubchem)
dNTP Pool
Pool identifier POOL000311
Members of this Pool
Members of control pools
POOL000310
Last modified: 10/Sep/2021
Results
Publication
Franzolin E, Coletta S, Ferraro P, Pontarin G, D'Aronco G, Stevanoni M, Palumbo E, Cagnin S, Bertoldi L, Feltrin E, Valle G, Russo A, Bianchi V, Rampazzo C: SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations., FASEB J, 2020

PubMed
Value 18.6
Dimension pmol/106 cell
Error (standard error) 5
Data presentation in publication diagram
Source
Source organism human (Homo sapiens)
Taxonomy 9606
Sample source cell line
Tissue type skin
Cell line/type as in publication skin fibroblasts derived cells; Patient 1
Compartment whole cell
Experiment Details
Measurement type dNTP incorporation assay
Extraction method methanol
Growth conditions DMEM with 4.5 g/L glucose, 10% (v/v) fetal calf serum (FCS), non-essential amino acids, and antibiotics; dNTP pool sizes were measured in quiescent cultures maintained for 10 days in 0.1% FCS serum
Treatment
Treatment details/effects Patient 1 (heterozygote carrying SAMHD1 mutations R145X and R164X)
Genes and Proteins
Gene name SAMHD1
Gene identifier 25939
Protein name Deoxynucleoside triphosphate triphosphohydrolase SAMHD1
Protein identifier Q9Y3Z3
Genetic manipulation/variation genetic variation
Mutation in protein R145X, R164X